Zhende Medical Co Stock Current Valuation
| 603301 Stock | 23.29 0.29 1.26% |
Valuation analysis of Zhende Medical helps investors to measure Zhende Medical's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns. At present, Zhende Medical's Total Cash From Operating Activities is projected to increase significantly based on the last few years of reporting. The current year's Begin Period Cash Flow is expected to grow to about 2.2 B, whereas Cash is forecasted to decline to about 1 B. Fundamental drivers impacting Zhende Medical's valuation include:
Price Book 1.0979 | Enterprise Value 6 B | Enterprise Value Ebitda 19.7832 | Price Sales 1.5467 | Trailing PE 30.8816 |
Overvalued
Today
Please note that Zhende Medical's price fluctuation is not too volatile at this time. Calculation of the real value of Zhende Medical is based on 3 months time horizon. Increasing Zhende Medical's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Zhende Medical is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Zhende Stock. However, Zhende Medical's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 23.29 | Real 19.11 | Hype 23.0 |
The real value of Zhende Stock, also known as its intrinsic value, is the underlying worth of Zhende Medical Company, which is reflected in its stock price. It is based on Zhende Medical's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Zhende Medical's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Zhende Medical Co helps investors to forecast how Zhende stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Zhende Medical more accurately as focusing exclusively on Zhende Medical's fundamentals will not take into account other important factors: Zhende Medical Co Company Current Valuation Analysis
Zhende Medical's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Zhende Medical Current Valuation | 6 B |
Most of Zhende Medical's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Zhende Medical Co is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Zhende Medical Co has a Current Valuation of 6 B. This is 58.26% lower than that of the Health Care Equipment & Supplies sector and 34.43% lower than that of the Health Care industry. The current valuation for all China stocks is 63.94% higher than that of the company.
Zhende Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Zhende Medical's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Zhende Medical could also be used in its relative valuation, which is a method of valuing Zhende Medical by comparing valuation metrics of similar companies.Zhende Medical is currently under evaluation in current valuation category among its peers.
Zhende Fundamentals
| Return On Equity | 0.0385 | ||||
| Return On Asset | 0.0156 | ||||
| Profit Margin | 0.05 % | ||||
| Operating Margin | 0.13 % | ||||
| Current Valuation | 6 B | ||||
| Shares Outstanding | 266.45 M | ||||
| Shares Owned By Insiders | 60.35 % | ||||
| Shares Owned By Institutions | 10.81 % | ||||
| Price To Book | 1.10 X | ||||
| Price To Sales | 1.55 X | ||||
| Revenue | 4.13 B | ||||
| Gross Profit | 1.74 B | ||||
| EBITDA | 462.31 M | ||||
| Net Income | 198.4 M | ||||
| Total Debt | 220.14 M | ||||
| Book Value Per Share | 20.96 X | ||||
| Cash Flow From Operations | 452.11 M | ||||
| Earnings Per Share | 0.76 X | ||||
| Target Price | 28.0 | ||||
| Number Of Employees | 6.72 K | ||||
| Beta | 0.43 | ||||
| Market Capitalization | 6.25 B | ||||
| Total Asset | 7.27 B | ||||
| Retained Earnings | 3.14 B | ||||
| Working Capital | 1.55 B | ||||
| Net Asset | 7.27 B | ||||
| Last Dividend Paid | 1.25 |
About Zhende Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Zhende Medical Co's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Zhende Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Zhende Medical Co based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Zhende Stock
Zhende Medical financial ratios help investors to determine whether Zhende Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Zhende with respect to the benefits of owning Zhende Medical security.